The enzymatic synthesis of PEPTIDES without an RNA template by processes that do not use the ribosomal apparatus (RIBOSOMES).
The production of PEPTIDES or PROTEINS by the constituents of a living organism. The biosynthesis of proteins on RIBOSOMES following an RNA template is termed translation (TRANSLATION, GENETIC). There are other, non-ribosomal peptide biosynthesis (PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT) mechanisms carried out by PEPTIDE SYNTHASES and PEPTIDYLTRANSFERASES. Further modifications of peptide chains yield functional peptide and protein molecules.
Ligases that catalyze the joining of adjacent AMINO ACIDS by the formation of carbon-nitrogen bonds between their carboxylic acid groups and amine groups.
Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES.
Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques.
A collection of cloned peptides, or chemically synthesized peptides, frequently consisting of all possible combinations of amino acids making up an n-amino acid peptide.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Small cationic peptides that are an important component, in most species, of early innate and induced defenses against invading microbes. In animals they are found on mucosal surfaces, within phagocytic granules, and on the surface of the body. They are also found in insects and plants. Among others, this group includes the DEFENSINS, protegrins, tachyplesins, and thionins. They displace DIVALENT CATIONS from phosphate groups of MEMBRANE LIPIDS leading to disruption of the membrane.
Peptides whose amino and carboxy ends are linked together with a peptide bond forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS. Some of them are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL).

How do peptide synthetases generate structural diversity? (1/1206)

Many low-molecular-weight peptides of microbial origin are synthesized nonribosomally on large multifunctional proteins, termed peptide synthetases. These enzymes contain repeated building blocks in which several defined domains catalyze specific reactions of peptide synthesis. The order of these domains within the enzyme determines the sequence and structure of the peptide product.  (+info)

Bacillus subtilis bacteriophages SP82, SPO1, and phie: a comparison of DNAs and of peptides synthesized during infection. (2/1206)

The genomes of Bacillus subtilis phages phie, SPO1, and SP82 were compared by DNA-DNA hybridization, analysis of DNA fragments produced by digestion with restriction endonucleases, comparison of the arrays of peptides synthesized during infection, and phage neutralization. DNA-DNA hybridization experiments indicated that about 78% of the SP82 DNA was homologous with SPO1 DNA, whereas 40% of the phie DNA was homologous to either SPO1 or SP82 DNA. Agarose gel electrophoresis was used to compare the molecular weights of DNA fragments produced by cleavage of SP82, SPO1, and phie DNAs with the restriction endonucleases Hae III, Sal I, Hpa II, and Hha I. Digestion of the DNAs with Hae III and Sal I produced only a few fragments, whereas digestion with Hpa II and Hha I yielded 29 to 40 fragments, depending on the DNA and the enzyme. Comparing the Hpa II fragments, 51% of the SP82 fragments had mobilities which matched those of SPO1 fragments, 32% of the SP82 fragments matched the phie fragments, and 34% of the SPO1 fragments matched the phie fragments. Comparing the Hha I digestion products, 62% of the SP82 fragments had mobilities matching the SPO1 fragments, 24% of the SP82 fragments matched the phie fragments, and 22% of the SPO1 fragments matched the phie fragments. Analysis of peptides by electrophoresis on one-dimensional sodium dodecyl sulfate-polyacrylamide slab gels showed that approximately 70 phage-specific peptides were synthesized in the first 24 min of each infection. With mobility and the intervals of synthesis as criteria, 66% of the different SP82 peptides matched the SPO1 peptides, 34% of the SP82 peptides matched the phie peptides, and 37% of the SPO1 peptides matched the phie peptides. Phage neutralization assays using antiserum to SP82 yielded K values of 510 for SP82, 240 for SPO1, and 120 for phie.  (+info)

Evidence for an adenovirus type 2-coded early glycoprotein. (3/1206)

We have identified an adenovirus type 2 (Ad2)-induced early glycopolypeptide with an apparent molecular weight of 20,000 to 21,000 (20/21K), as estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The 20/21K polypeptide could be labeled in vivo with [(3)H]glucosamine. [(35)S]methionine- and [(3)H]-glucosamine-labeled 20/21K polypeptides bound to concanavalin A-Sepharose columns and were eluted with 0.2 M methyl-alpha-d-mannoside. The pulse-labeled polypeptide appeared as a sharp band with an apparent molecular weight of 21K, but after a chase it converted to multiple bands with an average molecular weight of 20K. This variability in electrophoretic mobility is consistent with glycosylation or deglycosylation of the 20/21K polypeptide. Analysis of the pulse and pulse-chase-labeled forms by using partial proteolysis indicated that the polypeptides were highly related chemically, but not identical. Most of the 20/21K polypeptide is localized in the cytoplasm fraction of infected cells lysed by Nonidet P-40. The 20/21K polypeptide and a 44K polypeptide, labeled with [(35)S]methionine or [(3)H]glucosamine in Ad2-infected human cells, were precipitated by a rat antiserum against an Ad2-transformed rat cell line (T2C4), but not by antisera against three other Ad2-transformed rat cell lines, or by serum from nonimmune rats. The partial proteolysis patterns of the 20/21K and the 44K polypeptides were indistinguishable, indicating that the two polypeptides are highly related, and suggesting that the 44K polypeptide might be a dimer of the 20/21K polypeptide. The 20/21K polypeptide was also induced in Ad2-early infected monkey and hamster cells. These results imply that the 20/21K polypeptide is synthesized in Ad2-infected human, monkey, and hamster cells, and in one but not all Ad2-transformed rat cells. Thus, the 20/21K polypeptide is probably viral coded rather than cell coded and viral induced.  (+info)

Events following the infections of enucleate cells with measles virus. (4/1206)

The development of measles virus (Edmonston) and SSPE measles virus (Horta-Barbosa) has been examined in enucleate BSC 1 cells. New antigen synthesis in measles virus infected enucleate cells has been demonstrated by fluorescent antibody, by the formation of extensive syncytia from enucleate cells alone and by analysis of polypeptide formation by polyacrylamide gel electrophoresis. All polypeptides formed in nucleate cells were also present in enucleate cells but the amount synthesized was reduced to around 20% of that in nucleate cells. There was also a significant reduction in the amount of antigen detected by fluorescent antibody in enucleate as compared to nucleate preparations. Examination of RNA synthesis in infected enucleate cells revealed only a marginal increase in acid-insoluble material. Titration of the output of infectious virus from enucleate cells infected at both 37 and 31 degrees C indicated a consistent reduction of almost two log units compared to nucleate cells. That the enucleate cells were capable of replicating input genome at these times was demonstrated by the successful growth of respiratory syncytial virus, both at 37 and 31 degrees C. SSPE measles virus grew to higher yield in nucleate BSC 1 than measles virus but there was again a reduction of more than two log units in enucleate cells. All polypeptides synthesized in SSPE infected nucleate cells were apparent in enucleate cells.  (+info)

On the regulation of protein synthesis in vaccinia virus infected cells. (5/1206)

All eukaryotic mRNA species show a characteristic individual translational efficiency under conditions of restricted polypeptide chain initiation caused by an increase in the osmolarity of the growth medium. In vaccinia virus infected L cells or HeLa cells virus mRNAs can be grouped into classes on the basis of their relative labelling under standard and hypertonic conditions. Under the latter conditions, most of the "early" mRNAs possess very high translational efficiencies, most of the "intermediate" mRNAs show an intermediate efficiency and the most prominent "late" mRNAs show a translational efficiency which is lower than that of other virus mRNAs but still higher than the average cellular mRNA. Late in the infection cycle virus mRNAs with a relative low translational efficiency are preferentially translated under standard growth conditions whereas "early" virus mRNAs which are still present and which show a higher translational resistance to hypertonic conditions are not translated. These results indicate a unique translational control operating late in the growth cycle of vaccinia virus.  (+info)

Inhibition of vaccinia virus growth by the nucleoside analogue 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ribavirin). (6/1206)

Virazole or Ribavirin (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide) inhibits the growth of vaccinia virus at a concentration ode to a certain extent in the presence of Virazole, the DNA fails to acquire resistance to deoxyribonuclease and virus particles are not formed. Reversibility of the antiviral effect occurs when the drug is washed out from the infected cultures or when guanosine at an equimolar concentration is added.  (+info)

Conformational restraints revealing bioactive beta-bend structures for halpha CGRP8-37 at the CGRP2 receptor of the rat prostatic vas deferens. (7/1206)

1. The main aim of this study was to identify putative beta-bends and the role of the N- and C-terminus in the CGRP receptor antagonist halpha CGRP8-37, which was measured against halpha CGRP inhibition of twitch responses in the rat prostatic vas deferens. 2. With a bend-biasing residue (proline) at position 16 in halpha CGRP8-37 (10(-5) M) an inactive compound was produced, while alanine at the same position retained antagonist activity (apparent pKB 5.6+/-0.1 at 10(-5) M). Proline at position 19 within halpha CGRP8-37 (10(-5) M) was an antagonist (apparent pKB 5.8+/-0.1). 3. Incorporation of a bend-forcing structure (beta-turn dipeptide or BTD) at either positions 19,20 or 33,34 in halpha CGRP8-37 (10(-5) M) antagonized halpha CGRP responses (apparent pKB 6.0+/-0.1 and 6.1+/-0.1, respectively). Replacement by BTD at both positions 19,20 and 33,34 within halpha CGRP8-37 competitively antagonized responses to halpha CGRP (pA2 6.2; Schild plot slope 1.0+/-0.1). 4. Halpha CGRP8-37 analogues (10(-5) M), substituted at the N-terminus by either glycine8, or des-NH2 valine8 or proline8 were all antagonists against halpha CGRP (apparent pKB 6.1+/-0.1, 6.5+/-0.1 and 6.1+/-0.1, respectively), while halpha CGRP8-37 (10(-5) M) substituted in three places by proline8 and glutamic acid10,14 was inactive. 5. Replacement of the C-terminus by alanine amide37 in halpha CGRP8-37 (10(-5) M) failed to antagonize halpha CGRP responses. 6. Peptidase inhibitors did not alter either the agonist potency of halpha CGRP or the antagonist affinities of halpha CGRP8-37 BTD19,20 and 33,34 and halpha CGRP8-37 Gly8 (against halpha CGRP responses). 7. In conclusion, two beta-bends at positions 18-21 and 32-35 are compatible with high affinity by BTD and is the first approach of modelling the bioactive structure of halpha CGRP8-37. Further, the N-terminus of halpha CGRP8-37 is not essential for antagonism, while the C-terminus interacts directly with CGRP receptor binding sites of the rat vas deferens.  (+info)

Aminoacyl-CoAs as probes of condensation domain selectivity in nonribosomal peptide synthesis. (8/1206)

In nonribosomal biosynthesis of peptide antibiotics by multimodular synthetases, amino acid monomers are activated by the adenylation domains of the synthetase and loaded onto the adjacent carrier protein domains as thioesters, then the formation of peptide bonds and translocation of the growing chain are effected by the synthetase's condensation domains. Whether the condensation domains have any editing function has been unknown. Synthesis of aminoacyl-coenzyme A (CoA) molecules and direct enzymatic transfer of aminoacyl-phosphopantetheine to the carrier domains allow the adenylation domain editing function to be bypassed. This method was used to demonstrate that the first condensation domain of tyrocidine synthetase shows low selectivity at the donor residue (D-phenylalanine) and higher selectivity at the acceptor residue (L-proline) in the formation of the chain-initiating D-Phe-L-Pro dipeptidyl-enzyme intermediate.  (+info)

Nucleic acid-independent peptide biosynthesis refers to the process of producing peptides without the involvement of nucleic acids such as DNA or RNA. This is in contrast to the more common and well-known nucleic acid-dependent pathway, where genetic information encoded in DNA or RNA is transcribed and translated into a specific protein sequence.

In nucleic acid-independent peptide biosynthesis, peptides are generated through non-ribosomal mechanisms that involve large enzyme complexes called non-ribosomal peptide synthetases (NRPS). These enzymes directly assemble and modify amino acids into peptide bonds, creating a wide variety of structurally diverse peptides. This pathway is often observed in the biosynthesis of complex natural products, such as antibiotics, toxins, and siderophores, produced by various microorganisms like bacteria and fungi.

The NRPS-mediated process allows for the incorporation of non-proteinogenic amino acids and other building blocks into the peptide structure, expanding the chemical diversity beyond what can be achieved through ribosomal protein synthesis alone. This unique feature makes nucleic acid-independent peptide biosynthesis an essential area of study in natural product discovery, drug development, and synthetic biology.

Peptide biosynthesis is the process by which cells synthesize peptides, short chains of amino acids. This process is mediated by enzymes called peptide synthetases, which catalyze the formation of peptide bonds between individual amino acids to create a longer chain. Peptide biosynthesis typically occurs through one of two pathways: ribosomal or non-ribosomal.

Ribosomal peptide biosynthesis involves the use of the cell's translational machinery, including the ribosome and transfer RNAs (tRNAs), to synthesize peptides from a messenger RNA (mRNA) template. This process is highly regulated and typically results in the production of small, linear peptides that are further modified by enzymes to create bioactive molecules such as hormones or neurotransmitters.

Non-ribosomal peptide biosynthesis (NRPS), on the other hand, is a more complex process that involves large multifunctional enzyme complexes called non-ribosomal peptide synthetases (NRPSs). These enzymes are capable of synthesizing a wide variety of structurally diverse peptides, including cyclic and branched peptides, as well as those containing non-proteinogenic amino acids. NRPSs typically consist of multiple modules, each responsible for adding a single amino acid to the growing peptide chain. The modular nature of NRPS systems allows for great diversity in the types of peptides that can be synthesized, making them important sources of bioactive molecules with potential therapeutic applications.

Peptide synthases are a group of enzymes that catalyze the formation of peptide bonds between specific amino acids to produce peptides or proteins. They are responsible for the biosynthesis of many natural products, including antibiotics, bacterial toxins, and immunomodulatory peptides.

Peptide synthases are large, complex enzymes that consist of multiple domains and modules, each of which is responsible for activating and condensing specific amino acids. The activation of amino acids involves the formation of an aminoacyl-adenylate intermediate, followed by transfer of the activated amino acid to a thiol group on the enzyme. The condensation of two activated amino acids results in the formation of a peptide bond and release of adenosine monophosphate (AMP) and pyrophosphate.

Peptide synthases are found in all three domains of life, but are most commonly associated with bacteria and fungi. They play important roles in the biosynthesis of many natural products that have therapeutic potential, making them targets for drug discovery and development.

Peptides are short chains of amino acid residues linked by covalent bonds, known as peptide bonds. They are formed when two or more amino acids are joined together through a condensation reaction, which results in the elimination of a water molecule and the formation of an amide bond between the carboxyl group of one amino acid and the amino group of another.

Peptides can vary in length from two to about fifty amino acids, and they are often classified based on their size. For example, dipeptides contain two amino acids, tripeptides contain three, and so on. Oligopeptides typically contain up to ten amino acids, while polypeptides can contain dozens or even hundreds of amino acids.

Peptides play many important roles in the body, including serving as hormones, neurotransmitters, enzymes, and antibiotics. They are also used in medical research and therapeutic applications, such as drug delivery and tissue engineering.

A peptide fragment is a short chain of amino acids that is derived from a larger peptide or protein through various biological or chemical processes. These fragments can result from the natural breakdown of proteins in the body during regular physiological processes, such as digestion, or they can be produced experimentally in a laboratory setting for research or therapeutic purposes.

Peptide fragments are often used in research to map the structure and function of larger peptides and proteins, as well as to study their interactions with other molecules. In some cases, peptide fragments may also have biological activity of their own and can be developed into drugs or diagnostic tools. For example, certain peptide fragments derived from hormones or neurotransmitters may bind to receptors in the body and mimic or block the effects of the full-length molecule.

A peptide library is a collection of a large number of peptides, which are short chains of amino acids. Each peptide in the library is typically composed of a defined length and sequence, and may contain a variety of different amino acids. Peptide libraries can be synthesized using automated techniques and are often used in scientific research to identify potential ligands (molecules that bind to specific targets) or to study the interactions between peptides and other molecules.

In a peptide library, each peptide is usually attached to a solid support, such as a resin bead, and the entire library can be created using split-and-pool synthesis techniques. This allows for the rapid and efficient synthesis of a large number of unique peptides, which can then be screened for specific activities or properties.

Peptide libraries are used in various fields such as drug discovery, proteomics, and molecular biology to identify potential therapeutic targets, understand protein-protein interactions, and develop new diagnostic tools.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Antimicrobial cationic peptides (ACPs) are a group of small, naturally occurring peptides that possess broad-spectrum antimicrobial activity against various microorganisms, including bacteria, fungi, viruses, and parasites. They are called "cationic" because they contain positively charged amino acid residues (such as lysine and arginine), which allow them to interact with and disrupt the negatively charged membranes of microbial cells.

ACPs are produced by a wide range of organisms, including humans, animals, and plants, as part of their innate immune response to infection. They play an important role in protecting the host from invading pathogens by directly killing them or inhibiting their growth.

The antimicrobial activity of ACPs is thought to be mediated by their ability to disrupt the membranes of microbial cells, leading to leakage of cellular contents and death. Some ACPs may also have intracellular targets, such as DNA or protein synthesis, that contribute to their antimicrobial activity.

ACPs are being studied for their potential use as therapeutic agents to treat infectious diseases, particularly those caused by drug-resistant bacteria. However, their clinical application is still in the early stages of development due to concerns about their potential toxicity to host cells and the emergence of resistance mechanisms in microbial pathogens.

Cyclic peptides are a type of peptides in which the N-terminus and C-terminus of the peptide chain are linked to form a circular structure. This is in contrast to linear peptides, which have a straight peptide backbone with a free N-terminus and C-terminus. The cyclization of peptides can occur through various mechanisms, including the formation of an amide bond between the N-terminal amino group and the C-terminal carboxylic acid group (head-to-tail cyclization), or through the formation of a bond between side chain functional groups.

Cyclic peptides have unique structural and chemical properties that make them valuable in medical and therapeutic applications. For example, they are more resistant to degradation by enzymes compared to linear peptides, which can increase their stability and half-life in the body. Additionally, the cyclic structure allows for greater conformational rigidity, which can enhance their binding affinity and specificity to target molecules.

Cyclic peptides have been explored as potential therapeutics for a variety of diseases, including cancer, infectious diseases, and neurological disorders. They have also been used as tools in basic research to study protein-protein interactions and cell signaling pathways.

Finally, we describe the valinomycin biosynthetic gene cluster and reconstituted biosynthesis of valinomycin. With that, we ... and bioactivity to the identification of biosynthetic gene clusters and heterologous biosynthesis. In this review, we aim to ... Valinomycin is a nonribosomal peptide that was discovered from Streptomyces in 1955. Over the past more than six decades, it ... Valinomycin is a nonribosomal peptide that was discovered from Streptomyces in 1955. Over the past more than six decades, it ...
Zheng, Yiwu ; Nair, Satish K. / YcaO-mediated ATP-dependent peptidase activity in ribosomal peptide biosynthesis. In: Nature ... Zheng, Y., & Nair, S. K. (2023). YcaO-mediated ATP-dependent peptidase activity in ribosomal peptide biosynthesis. Nature ... YcaO-mediated ATP-dependent peptidase activity in ribosomal peptide biosynthesis. / Zheng, Yiwu; Nair, Satish K. In: Nature ... Zheng, Y & Nair, SK 2023, YcaO-mediated ATP-dependent peptidase activity in ribosomal peptide biosynthesis, Nature chemical ...
New peptides that can travel through membranes unleashing the potential of peptide drugs ... 2021 - ARC Centre of Excellence for Innovations in Peptide and Protein Science ...
Lloyd D. Fricker (24 July 1991). Peptide biosynthesis and processing. CRC Press. p. 78. ISBN 978-0-8493-8852-1. Retrieved 25 ... Corticotropin-Like+Intermediate+Lobe+Peptide at the U.S. National Library of Medicine Medical Subject Headings (MeSH) (Genes on ... Chastrette N, Cespuglio R, Lin YL, Jouvet M (February 1990). "Proopiomelanocortin (POMC)-derived peptides and sleep in the rat ... Marshall JB, Kapcala LP, Manning LD, McCullough AJ (November 1984). "Effect of corticotropin-like intermediate lobe peptide on ...
Si, Y., Kretsch, A. M., Daigh, L. M., Burk, M. J., & Mitchell, D. A. (2021). Cell-Free Biosynthesis to Evaluate Lasso Peptide ... Cell-Free Biosynthesis to Evaluate Lasso Peptide Formation and Enzyme-Substrate Tolerance. In: Journal of the American Chemical ... Cell-Free Biosynthesis to Evaluate Lasso Peptide Formation and Enzyme-Substrate Tolerance. Journal of the American Chemical ... Cell-Free Biosynthesis to Evaluate Lasso Peptide Formation and Enzyme-Substrate Tolerance. / Si, Yuanyuan; Kretsch, Ashley M.; ...
The trefoil peptides, rat spasmolytic polypeptide (rSP) and rat intestinal trefoil factor (rITF), along with ep … ... encoding peptides considered to play active parts in the healing response. ... Epidermal Growth Factor / biosynthesis * Gastric Mucosa / metabolism* * Gastric Mucosa / pathology * Gene Expression ... encoding peptides considered to play active parts in the healing response. The trefoil peptides, rat spasmolytic polypeptide ( ...
Structure of the terminal PCP domain of the non-ribosomal peptide synthetase in teicoplanin biosynthesis,. *Post by: CIPPS ... Structure of the terminal PCP domain of the non-ribosomal peptide synthetase in teicoplanin biosynthesis,. ... Structure of the terminal PCP domain of the non-ribosomal peptide synthetase in teicoplanin biosynthesis, ... New peptides that can travel through membranes unleashing the potential of peptide drugs ...
... and brain natriuretic peptide (BNP) was examined by using ex vivo models of human fat. The effects of inducible low-grade ... Reciprocal effects of systemic inflammation and brain natriuretic peptide on adiponectin biosynthesis in adipose tissue of ... Reciprocal effects of systemic inflammation and brain natriuretic peptide on adiponectin biosynthesis in adipose tissue of ... adiponectin, adipose tissue, heart failure, inflammation, natriuretic peptide, brain, Adiponectin, Adipose Tissue, Aged, ...
Jenner M, Hai Y, Nguyen HH, Passmore M, Skyrud W, Kim J, Garg NK, Zhang W, Ogorzalek Loo RR, Tang Y. Elucidating the molecular programming of a nonlinear non…
Characterization of the macrocyclase involved in the biosynthesis of RiPP cyclic peptides in plants ... Characterization of the macrocyclase involved in the biosynthesis of RiPP cyclic peptides in plants. Download. *View final ... Characterization of the macrocyclase involved in the biosynthesis of RiPP cyclic peptides in plants. From National Research ... Characterization of the macrocyclase involved in the biosynthesis of RiPP cyclic peptides in plants (PDF, 6.1 MiB) ...
Antimicrobial Cationic Peptides / biosynthesis* * Biopsy * Castleman Disease / complications* * Castleman Disease / diagnosis * ...
Engineered biosynthesis of the peptide antibiotic bacitracin in the surrogate host Bacillus subtilis. J Biol Chem. 2001;276: ...
Structure elucidation and biosynthesis of lysine-rich cyclic peptides in Xenorhabdus nematophila.. Org Biomol Chem. 9 (2011) ... Enzyme-cleavable tandem peptides for quantitative studies in MS-based proteomics.. Proteomics 12(2012) 3470-4. ... for peptides and proteins.. J. Am. Soc. Mass Spectrom. 23 (2012) 1949-54. ...
Eipper, B.A.; Mains, R.E. The role of ascorbate in the biosynthesis of neuroendocrine peptides. Am. J. Clin. Nutr. 1991, 54 ( ... The biosynthesis of many amidated peptide-based hormones, including oxytocin, vasopressin, thyrotropin-releasing hormone, and ... Rebouche, C.J. Ascorbic acid and carnitine biosynthesis. Am. J. Clin. Nutr. 1991, 54 (Suppl. S6), 1147S-1152S. [Google Scholar ... Prigge, S.T.; Mains, R.E.; Eipper, B.A.; Amzel, L.M. New insights into copper monooxygenases and peptide amidation: Structure, ...
... and biosynthesis by peptide and polyketide synthetases. Microbiol. Mol. Biol. Rev. 1999, 63, 266-292. [Google Scholar] ... The biosynthesis of phytotoxins, such as coronofacic acid (cfa) and syringomycin, are described as important pathogenicity ... 119] observed that mutants in the LPS biosynthesis cluster of P. atrosepticum SCRI1043 led to a reduction in potato soft rot. ... Diversity and evolution of the phenazine biosynthesis pathway. Appl. Environ. Microbiol. 2010, 76, 866-879. [Google Scholar] [ ...
Phylogenetic study of polyketide synthases and nonribosomal peptide synthetases involved in the biosynthesis of mycotoxins. ... Some microorganisms were not only able to degrade OTA, but also able to inhibit the biosynthesis of OTA. El Khoury et al. (2017 ... Harris, J. P., and Mantle, P. G. (2001). Biosynthesis of ochratoxins by Aspergillus ochraceus. Phytochemistry 58, 709-716. doi ... Gallo, A., Ferrara, M., and Perrone, G. (2017). Recent advances on the molecular aspects of Ochratoxin A biosynthesis. Curr. ...
A fluorescence-based assay is used to screen cyclic peptides for their activity in preventing protein misfolding, an event that ... Biochemical, biophysical and biological assays using isolated amyloid β peptide, primary neurons and various established ... We demonstrate the effectiveness of this approach by identifying drug-like, head-to-tail cyclic peptides that modulate the ... disease nematode models showed that the selected macrocycles potently inhibit the formation of neurotoxic amyloid β peptide ...
Fatty acid biosynthesis. 4.17. map01053. Biosynthesis of siderophore group nonribosomal peptides. 3.47. map01040. Biosynthesis ... PlmKR1-Ketoreductase from the first module of phoslactomycin biosynthesis in Streptomyces sp. HK803. ...
The biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with ... "Protein Biosynthesis" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical ... This graph shows the total number of publications written about "Protein Biosynthesis" by people in this website by year, and ... Below are the most recent publications written about "Protein Biosynthesis" by people in Profiles. ...
GAG biosynthesis is initiated by peptide O-xylosyltransferases, which transfer xylose onto selected serine residues in the core ... A constriction within the peptide binding cleft requires the acceptor serine to be followed by glycine or alanine. The ... Structural Basis for the Initiation of Glycosaminoglycan Biosynthesis by Human Xylosyltransferase 1.. Briggs, D.C., Hohenester ... and various acceptor peptides. The structures reveal unique active-site features that, in conjunction with functional ...
Ribosome-Independent Biosynthesis of Peptide Natural Products: Nonribosomal Peptide Synthetases and Cyclodipeptide Synthases by ... Jing Liu, the biosynthesis of streptoazine C and guanitrypmycin D1 was elucidated. Firstly, a three-gene cluster coding for a ... Liujuan Zheng, the biosynthesis of a highly oxygenated phenethyl derivative ustethylin A, isolated from Aspergillus ustus, was ... Investigation on the biosynthesis of polyketides in two Penicillium strains by: Xiang, Pan Published: (2022) ...
Structural basis of CTP-dependent peptide bond formation in coenzyme A biosynthesis catalyzed by Escherichia coli PPC ... Biosynthesis of riboflavin in archaea studies on the mechanism of 3,4-dihydroxy-2-butanone-4-phosphate synthase of ... and phylogenetic distribution of isoprenoid biosynthesis pathways. European Journal of Biochemistry 271 (13), pp. 2658 - 2669 ( ... 4-cyclodiphosphate synthase involved in mevalonate-independent biosynthesis of isoprenoids. Journal of Molecular Biology 316 (1 ...
Plasma elastase activity (EA) and plasma elastin-derived peptide concentration (EDPc) were measured. Results:There were ... Keywords: young adult, Transplantation, Homologous, Peptide Fragments - biosynthesis, Pancreatic Elastase - metabolism, ... Plasma elastase activity (EA) and plasma elastin-derived peptide concentration (EDPc) were measured.. Results. There were ...
Peptide Biosynthesis [G02.111.660] * Aminoacylation [G02.111.660.050] * Peptide Biosynthesis, Nucleic Acid-Independent [G02.111 ... non-ribosomal peptide biosynthesis (PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT) mechanisms carried out by PEPTIDE SYNTHASES ... non-ribosomal peptide biosynthesis (PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT) mechanisms carried out by PEPTIDE SYNTHASES ... Further modifications of peptide chains yield functional peptide and protein molecules.. Terms. Peptide Biosynthesis Preferred ...
N-Phenylacetylation and Nonribosomal Peptide Synthetases with Substrate Promiscuity for Biosynthesis of Heptapeptide Variants, ... Biosynthesis and Degradation of Sulfur Modifications in tRNAs.. INT J MOL SCI. 2021 Nov 3;22(21):11937. doi: 10.3390/ ... Bacterial Avenalumic Acid Biosynthesis Includes Substitution of an Aromatic Amino Group for Hydride by Nitrous Acid Dependent ... An Unprecedented Cyclization Mechanism in the Biosynthesis of Carbazole Alkaloids in Streptomyces. Angew Chem Int Ed Engl. 189 ...
CMcCrory, Effect of Rhizotomy and Spinal Cord Stimulation on spinal neuroimmune peptide biosynthesis in vivo in man, Guys& ... peptide and proteomic constituents in patient responders with chronic neuropathic pain, J. Neuroimmunology, 2020 Journal ...
The essential role of vitamin D in the biosynthesis of endogenous antimicrobial peptides may explain why deficiency increases ... In the lungs, formation of the peptide LL37, an innate immune system component that, among other things, attacks enveloped ... Vitamin D deficiency and air pollution exacerbate COVID-19 through suppression of antiviral peptide LL37. Front Public Health. ...
THIAZOLE BIOSYNTHETIC ENZYME IN YEAST FAD MITOCHONDRION NTHIAMINE BIOSYNTHESIS TRANSIT PEPTIDE BIOSYNTHETIC PROTEI ...
Inhibits the transpeptidation (cross-linking) step of cell wall biosynthesis by binding to the peptide-bridging segments of the ... Inhibits the transglycosylation (polymerization) step of cell wall biosynthesis by binding to the stem peptide of peptidoglycan ...

No FAQ available that match "peptide biosynthesis"

No images available that match "peptide biosynthesis"